 CANTON, Mass., Nov. 09, 2020 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today reported financial results for the three and nine months ended September 30, 2020. 